Science Advances · 2019 · 29 citations · 35 references
Life SciencesCancer BiologyMolecular BiologyMolecular OncologyMolecular VirologyVirologyAntiviral TherapyPost-translational RegulationProtein DegradationViral HepatitisViral Hepatitis TreatmentViral Protein ProcessingHepatitis B Virus ReactivationHepatitis B Virus ReplicationProteasomal TurnoverProteasome Inhibitor TherapyProteasome InhibitorsProteasome-mediated DegradationTyrosine Kinase InhibitionUbiquitin-mediated Proteolysis
axis or pharmaceutical inhibition of this process stabilizes HBV polymerase protein and increases viral loads in HBV-infected liver cancer cell lines. Our study reveals a kinase-dependent activation of CRL4 ubiquitin ligase that can be targeted for blocking HBV replication.
35
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy, Peter G. Smith, Michael A. Milhollen et al. · Nature · 2009 · 2K citations
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Krönke, Namrata D. Udeshi, Anupama Narla et al. · Science · 2013 · 1.8K citations · Full text
Medicine, Cell Biology, Oncology +14
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu, Richard E. Middleton, Huahang Sun et al. · Science · 2013 · 1.6K citations · Full text
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Kasia Hrecka, Caili Hao, Magda Gierszewska et al. · Nature · 2011 · 1.2K citations